Abstract
In a patient with acute myeloid leukemia (AML) following therapy, finding ≥5% bone marrow (BM) blasts is highly concerning for residual/relapsed disease. Over an 18-month period, we performed multicolor flow cytometry immunophenotyping (MFC) for AML minimal residual disease on >4,000 BM samples, and identified 41 patients who had ≥5% myeloblasts by morphology but negative by MFC. At the time of a negative MFC study, an abnormal cytogenetic study converted to negative in 14 patients and remained positive at a low level (2.5-9.5%) by fluorescence in situ hybridization in 3 (14%), of the latter, abnormalities subsequently disappeared in the repeated BM in 2 patients. Positive pretreatment mutations, including FLT3, NPM1, IDH1, CEBPA, became negative in all 10 patients tested. Of the seven patients with favorable cytogenetics, PML/RARA, CBFB-MYH11 or RUNX1-RUNX1T1 fusion transcripts were detected at various levels in six patients but all patients remained in complete remission. With no additional chemotherapy given, 39 patients had BM repeated (median 2 weeks, range <1-21), and all cases showed <5% BM blasts and a continuously negative MFC. In the end of follow-up (median 10 months, range 1-22), 13 patients experienced relapse, 12/...Continue Reading
References
Sep 16, 1998·Leukemia·G MarcucciM A Caligiuri
Sep 30, 1999·The New England Journal of Medicine·B LöwenbergA Burnett
Feb 16, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·F MorschhauserC Preudhomme
Mar 13, 2001·Leukemia·J E SarrieraE Estey
Jun 1, 2002·Leukemia·A GuerrasioG Saglio
Jul 26, 2002·British Journal of Haematology·Bert A van der ReijdenJoop H Jansen
Dec 16, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bruce D ChesonUNKNOWN International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards
Nov 11, 2005·Leukemia·G PereaUNKNOWN Grupo Cooperativo para el Estudio y Tratamiento de las Leucemias Agudas y Miel
Nov 3, 2009·Blood·Hartmut DöhnerUNKNOWN European LeukemiaNet
Nov 9, 2011·Clinical Lymphoma, Myeloma & Leukemia·Jeffrey L Jorgensen, Su S Chen
Nov 1, 2011·Blood·Francesco BuccisanoAdriano Venditti
Jan 13, 2012·Nature·Li DingJohn F DiPersio
Mar 16, 2012·The New England Journal of Medicine·Matthew J WalterTimothy A Graubert
Jun 1, 2012·Blood·Michael R LokenSoheil Meshinchi
Jul 24, 2012·Cell·John S WelchRichard K Wilson
Aug 11, 2012·Journal of the National Comprehensive Cancer Network : JNCCN·Farhad Ravandi, Jeffrey L Jorgensen
Aug 25, 2012·Blood·Elisabeth Paietta
Sep 12, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Hiroto InabaDario Campana
Feb 6, 2013·Current Opinion in Hematology·Elaine Coustan-Smith, Dario Campana
Mar 26, 2013·American Journal of Hematology·Elihu H Estey
Jun 27, 2013·Nature Reviews. Clinical Oncology·Christopher S Hourigan, Judith E Karp
Jul 3, 2013·The Journal of Molecular Diagnostics : JMD·Rajesh R SinghRajyalakshmi Luthra
Jul 13, 2013·Blood·Roland B WalterFrederick R Appelbaum
Sep 26, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Monique TerwijnGerrit J Schuurhuis
Sep 26, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sylvie D FreemanAlan K Burnett
Oct 24, 2013·Cytometry. Part B, Clinical Cytometry·W ZeijlemakerG J Schuurhuis
Nov 19, 2013·Cytometry. Part B, Clinical Cytometry·Michael R Loken
May 21, 2014·Bone Marrow Transplantation·J M JasoP Lin
Jun 4, 2014·Leukemia·R B WalterB M Sandmaier
Nov 6, 2014·British Journal of Haematology·Gro G PløenAnni Aggerholm
Citations
Aug 22, 2015·Leukemia & Lymphoma·Jie PengSa A Wang
Jun 27, 2015·Seminars in Hematology·Peter HoklandChristopher S Hourigan
Jun 15, 2016·American Journal of Clinical Pathology·Juan OuyangSa A Wang
May 19, 2016·Genes, Chromosomes & Cancer·Louise PetterssonMats Ehinger
Sep 23, 2016·Cancer·Farhad RavandiHagop Kantarjian
Apr 17, 2016·Journal of Clinical Pathology·Lanshan HuangSa A Wang
Aug 8, 2015·American Journal of Hematology·Neil CameSurender Juneja
Mar 31, 2018·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sylvie D FreemanNigel H Russell
Feb 14, 2019·Annals of Hematology·Wei XieGuilin Tang
Apr 2, 2020·Blood·Robert P HasserjianBenjamin L Ebert
Dec 7, 2019·Hematology·Sylvie D Freeman, Christopher S Hourigan
Jul 11, 2018·World Journal of Stem Cells·Cristina MambetCarmen Cristina Diaconu
Feb 9, 2020·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Wei XieGuilin Tang
Dec 7, 2018·British Journal of Haematology·Sylvie D FreemanUNKNOWN HOVON AML Trial Group
Jan 18, 2017·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Lina HanMarina Konopleva
Dec 23, 2020·Blood Advances·Nicholas J ShortFarhad Ravandi
Feb 23, 2021·Pathology·Rithin NedumannilSurender Juneja
Sep 30, 2021·International Journal of Laboratory Hematology·Paul F McGowanDa Zhang